Filter By Industry
Filter By Tag

Newsroom

Mellalta Meets Press releases

11 - 13 of 13 Press Releases

Daiichi Sankyo's first in-human study of DS-1062 (Antibody Drug Conjugate) in TNBC and NSCLC
Jul 10, 2020
Daiichi Sankyo's DS-1062 is a TROP2-directed antibody drug conjugate (ADC), designed using Daiichi Sankyo's proprietary DXd ADC technology with the highest development stage of Phase I.

KRAS inhibitors-Market opportunity, Epidemiology, Forecast,Pipeline and Competitive Analysis, 2020-2
Jul 09, 2020
Kirsten rat sarcoma viral oncogene homolog (KRAS) mutation may directly influence medical decisions in patients with carcinomas as demonstrated by the recent research.

Akili's Endeavor Market Sales Potential and Endeavor Commercialization Plans
Jun 29, 2020
Mellalta Meets is quite optimistic about Endeavor's sales potential. I


Page: Prev 1 2
Mellalta Meets RSS Feed